Patents Examined by Sabiha Qazi
  • Patent number: 6844456
    Abstract: The present invention is directed to modified, hydroxy-bearing aromatic ring structures having cytoprotective activity. More specifically, in a first embodiment the present invention is directed to phenolic compounds, and in particular steriods (e.g., estrogens), wherein a non-fused polycyclic, hydrophobic substituent is attached to the hydroxy-substituted A-ring thereof. The present invention is further directed to a process for conferring cytoprotection to a population of cells involving the administration of the compound.
    Type: Grant
    Filed: November 5, 2001
    Date of Patent: January 18, 2005
    Assignee: Washington University
    Inventor: Douglas F. Covey
  • Patent number: 6844294
    Abstract: Described are herbicidal compositions comprising A) at least one compound from the benzoylcyclohexanedione group and B) at least one compound from the group of the herbicides which act selectively against monocotyledonous and/or dicotyledonous harmful plants in rice. These compositions have a superior action compared with the herbicides employed individually.
    Type: Grant
    Filed: April 18, 2002
    Date of Patent: January 18, 2005
    Assignee: Aventis CropScience GmbH
    Inventors: Thomas Auler, Andreas van Almsick, Erwin Hacker, Jean-Claude Millet, Keiji Endo
  • Patent number: 6841690
    Abstract: This invention relates to a series of novel compounds having the general structures A and B: including 2-azido-2-azidomethyl-1,3-diazidopropane (1), 2-azidomethyl-2-hydroxy-1,3-diazidopropane (2), 2-azidomethyl-2-nitrato-1,3-diazidopropane (3), 2-azidomethyl-2-nitro-1,3-diazidopropane (4), 2,2-dinitro-1,3-diazidopropane (5), methallyidiazide (6), a dimer of methallyidiazide (6), comprising 3a,8a-Bis-azidomethyl-3a,4,8a,9-tetrahydro-3H,8H-bis[1,2,3]triazolo[1,5-a;1?,5?-d]pyrazine (6-Dimer), 1,3-diazidoacetone (7), and 2-Oximido-1,3-diazidopropane (8). Also shown are reaction intermediates of these compounds, including 2,2-bis(chloromethyl)oxirane (9), and 2,2-bis(azidomethyl)oxirane (10).
    Type: Grant
    Filed: August 15, 2003
    Date of Patent: January 11, 2005
    Assignee: The United States of America, as represented by the Secretary of the Army
    Inventors: Paritosh R. Dave, Raja G. Duddu, Reddy Damavarapu, Nathaniel Gelber, Kathy Yang, C. Rao Surapaneni
  • Patent number: 6831039
    Abstract: The invention relates to 3-(heterocyclyl)-substituted benzoylpyrazois of formula (I), wherein the variables have the following meanings: X is O, NH or N-alkyl; R1 is alkyl; R2, R3, R4, R5 are hydrogen, alkyl or alkyl halide; R6 is halogen, nitro, alkyl halide, alkoxy, halogenalkoxy, alkylthio, halogenalkylthio, alkylsulfonyl or halogenalkylsulfonyl; R7 is hydroxy, alkoxy, alkenyloxy, alkylsulfonyloxy, alkylcarboyloxy, alkylthiocarbonyloxy, phenylsulfonyloxy or phenylcarbonyloxy, and the phenyl radical can be substituted; R8, R9 are alkyl; R10 is hydrogen or alkyl; and R11 is hydrogen or alkyl; and to their agriculturally useable salts. The invention also relates to intermediate products and methods for producing the inventive compounds and to the use of these compounds or products containing them for combating undesirable plants.
    Type: Grant
    Filed: May 21, 2001
    Date of Patent: December 14, 2004
    Assignee: BASF Aktiengesellschaft
    Inventors: Ulf Neidlein, Norbert Götz, Ernst Baumann, Wolfgang von Deyn, Steffen Kudis, Klaus Langemann, Guido Mayer, Ulf Misslitz, Matthias Witschel, Martina Otten, Karl-Otto Westphalen, Helmut Walter
  • Patent number: 6831199
    Abstract: The present invention relates to a class of compounds represented by the Formula I or a pharmaceutically acceptable salt thereof, wherein A is pharmaceutical compositions thereof and methods of using such compounds and compositions as &agr;v&bgr;3 antagonists.
    Type: Grant
    Filed: December 18, 1998
    Date of Patent: December 14, 2004
    Assignee: G. D. Searle & Co.
    Inventors: Peter Gerrard Ruminski, Michael Clare, Paul Waddell Collins, Bipinchandra Nanubhai Desai, Richard John Lindmark, Joseph Gerace Rico, Thomas Edward Rogers, Mark Andrew Russell
  • Patent number: 6831073
    Abstract: A method of treating estrogenic deficiencies in women while further avoiding the appearance of osteoporosis, withdrawal bleeding and cardiovascular diseases in post-menopausal women without any androgenic effect, and no deleterious effects on blood vessels comprising continuously without interruption administering to said women, a combination of 0.5 to 3 mg of an estrogenic compound and 1.5 to 3.75 mg of nomegestrol acetate.
    Type: Grant
    Filed: March 17, 1999
    Date of Patent: December 14, 2004
    Assignee: Laboratoire Theramex
    Inventors: Michel Lanquetin, Jacques Paris, Jean-Louis Thomas
  • Patent number: 6825360
    Abstract: The invention relates to novel bicyclic aromatic compounds which have the general formula (I): as well as to the use of these compounds in pharmaceutical compositions intended for use in human or veterinary medicine (dermatological, rheumatic, respiratory, cardiovascular and ophthalmological complaints in particular), or alternatively in cosmetic compositions.
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: November 30, 2004
    Assignee: Galderma Research & Development S.N.C.
    Inventor: Jean-Michel Bernardon
  • Patent number: 6821926
    Abstract: The invention provides synergistic active compound combinations which are comprised of a carbamoyltriazolinone and at least one herbicidally active compound. The combinations of the present invention find use in controlling plant growth, including weeds.
    Type: Grant
    Filed: May 14, 2002
    Date of Patent: November 23, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Dieter Feucht, Peter Dahmen, Mark Wilhelm Drewes, Rolf Pontzen, Mathias Kremer, Klaus-Helmut Müller
  • Patent number: 6815563
    Abstract: A process for preparing bicyclic 1,3-diketones of the formula I where R1, R2, R3 and R4 are hydrogen, C1-C4-alkyl, C1-C4-alkoxy-carbonyl, halogen, cyano, nitro, C1-C4-alkylthio, C1-C4-alkylsulfenyl or C1-C4-alkylsulfonyl and Z is C1-C4-alkylene, O, S, N—R5 where R5 is C1-C4-alkyl or C1-C4-alkylcarbonyl, which comprises a) reacting a bicyclic olefin of the formula II with haloform in the presence of a base to give the ring-expanded product of the formula III  where R1-R4 and Z are as defined above and X is halogen; b) hydrolyzing the allylic halogen of the compound of the formula III to the allyl alcohol of the formula IV c) oxidizing the allyl alcohol of the formula IV to the unsaturated ketone of the formula V d) reacting the ketone of the formula V with a nucleophilic ion Y− which stabilizes a negative charge to give the ketone of the formula VI e) hydrolyzing the ketone of the formula VI to th
    Type: Grant
    Filed: January 6, 2003
    Date of Patent: November 9, 2004
    Assignee: BASF Aktiengesellschaft
    Inventors: Klaus Langemann, Ulf Misslitz, Ernst Baumann, Wolfgang von Deyn, Steffen Kudis, Thorsten Volk, Guido Mayer
  • Patent number: 6812349
    Abstract: The invention relates to compounds of formula (2) in which R1, R2, R3 and R4 have the meanings indicated in the description, their preparation and their further reaction to give compounds of formula (1), in which A1, A2 and R4 have the meanings indicated in the description. The compounds of the formula (1) are valuable intermediates for the preparation of medicaments.
    Type: Grant
    Filed: September 23, 2003
    Date of Patent: November 2, 2004
    Assignee: Altana Pharma AG
    Inventors: Wolf-Rüdiger Ulrich, Christian Scheufler, Thomas Fuchss, Jörg Senn-Bilfinger
  • Patent number: 6812358
    Abstract: A novel process for making estra-4,9(10)-diene-3,17-dione steroids from readily available 19-nor-androst-4-ene-3-one steroids by a straightforward three-step process. Products of this process are important intermediates in the preparation of biologically active substances.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: November 2, 2004
    Assignee: Bridge Organics Co.
    Inventors: Verlan H. Van Rheenen, Edward J. Hessler
  • Patent number: 6809064
    Abstract: Described are herbicidal compositions comprising A) at least one compound from the benzoylcyclohexanedione group and B) at least one compound from the group of the herbicides which act selectively against monocotyledonous and/or dicotyledonous harmful plants in rice. These compositions have a superior action compared with the herbicides employed individually.
    Type: Grant
    Filed: April 18, 2002
    Date of Patent: October 26, 2004
    Assignee: Aventis CropScience GmbH
    Inventors: Thomas Auler, Andreas van Almsick, Erwin Hacker, Jean-Claude Millet, Keiji Endo
  • Patent number: 6797673
    Abstract: Spray of discharge drift is controlled in aqueous mixtures with the inclusion of a substantially neutral pH drift control agent containing lecithin, a viscosity modifying agent, and a water dispersing agent. In one embodiment, the viscosity modifying agent is a methyl ester and the water dispersing agent is a polyoxyethylene ether. In a preferred embodiment the viscosity modify agent is methyl soyate and the water dispersing agent has the formula H23C11(CH2CH2O)5H. The lecithin-based drift control agents of the present invention reduce the formation of fine droplets when the mixtures are atomized, thereby reducing the amount of the mixture that drifts outside of the area targeted to receive the spray or discharge.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: September 28, 2004
    Assignee: Platte Chemical Company
    Inventors: Randall Worthley, Daniel Bergman
  • Patent number: 6794503
    Abstract: Described herein is a process for the preparation of 6&agr;-fluorosteroids of formula (I), in which R is chosen from H, OH and an alkyl group with from 1 to 4 carbon atoms and R′ is a carboxyalkyl group with from 1 to 4 carbon atoms in the alkyl chain, comprising the selective fluorination at the 6&agr;-position by treatment of the compound of formula (III), wherein R and R′ are as defined above, with an electrophilic fluorinating agent.
    Type: Grant
    Filed: May 16, 2001
    Date of Patent: September 21, 2004
    Assignee: Farmabios S.r.l.
    Inventors: Filippo La Loggia, Marco Da Col
  • Patent number: 6787659
    Abstract: The present invention relates to a process for the synthesis of oxandrolone from mestanolone. The process comprises the steps of: (a) oxidizing mestanolone to form 17&bgr;-hydroxy-17&agr;-methyl-5&agr;-androst-1-en-3-one; (b) hydroxylating the 17&bgr;-hydroxy-17&agr;-methyl-5&agr;-androst-1-en-3-one to form 1&agr;, 2&agr;, 17&bgr;-trihydroxy-17&agr;-methylandrostan-3-one; (c) cleaving the 1&agr;, 2&agr;, 17&bgr;-trihydroxy-17&agr;-methylandrostan-3-one to form 17&bgr;-hydroxy-17&agr;-methyl-1-oxo-1,2,-seco-A-nor-5&agr;-androstan-2-oic acid; and (d) reducing the 17&bgr;-hydroxy-17&agr;-methyl-1-oxo-1,2,-seco-A-nor-5&agr;-androstan-2-oic acid to form oxandrolone.
    Type: Grant
    Filed: December 11, 2001
    Date of Patent: September 7, 2004
    Assignee: Barr Laboratories, Inc.
    Inventors: Shaileshkumar Ramanlal Desai, David Wayne Ray, Jr., Yousry A. Sayed
  • Patent number: 6780855
    Abstract: This invention describes the new 11&bgr;-halogen-7&agr;-substituted estratrienes of general formula I in which R11 is a fluorine or chlorine atom, and the other substituents have the meanings that are explained in more detail in the description. The compounds have antiestrogenic properties or tissue-selective estrogenic properties and are suitable for the production of pharmaceutical agents.
    Type: Grant
    Filed: December 2, 1999
    Date of Patent: August 24, 2004
    Assignee: Schering Aktiengesellschaft
    Inventors: Rolf Bohlmann, Nikolaus Heinrich, Helmut Hofmeister, Jorg Kroll, Hermann Kunzer, Gerhard Sauer, Ludwig Zorn, Karl-Heinrich Fritzemeier, Monika Lessl, Rosemarie Lichtner, Yukishige Nishino, Karsten Parczyk, Martin Schneider
  • Patent number: 6780992
    Abstract: The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. This invention particularly relates to novel azolidinedione derivatives of the general formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them.
    Type: Grant
    Filed: December 26, 2001
    Date of Patent: August 24, 2004
    Assignees: Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories Inc.
    Inventors: Vidya Bhushan Lohray, Braj Bhushan Lohray, Rao Bheema Paraselli, Ranga Madhavan Gurram, Rajagopalan Ramanujam, Ranjan Chakrabarti, Sarma K.S. Pakala
  • Patent number: 6780854
    Abstract: Novel, orally active androgens are 7&agr;-substituted &Dgr;14-nandrolone derivatives. The compounds satisfy the general formula: wherein R1 is O, (H,H), (H,OR), NOR, with R being hydrogen, (C1-6) alkyl, or (C,1-6) acyl; R2 is selected from the group consisting of (C2-4) alkyl, (C2-4) alkenyl, or (C2-4) alkynyl, each optionally substituted by halogen; or R2 is cyclopropyl, or cyclopropenyl, each optionally substituted by (C1-2) alkyl, or halogen; R3 is hydrogen, (C1-2) alkyl, or ethenyl; R4 is (C1-2) alkyl; R5 is hydrogen, or (C1-15) acyl; and the dotted lines indicate optional bonds.
    Type: Grant
    Filed: October 24, 2002
    Date of Patent: August 24, 2004
    Assignee: Akzo Nobel NV
    Inventors: Hubert Jan Jozef Loozen, Dirk Leysen, Jaap van der Louw
  • Patent number: 6777401
    Abstract: A solvent comprising a combination of water and organic solvent(s) capable of dissolving a therapeutically effective amount of medicament(s) not readily soluble in aqueous solvents, said organic solvents including alcohol and glycol, and said medicaments including hydrocortisone.
    Type: Grant
    Filed: October 24, 2002
    Date of Patent: August 17, 2004
    Assignee: Blansett Pharmacal, Co., Inc.
    Inventor: Calvin Hanna
  • Patent number: RE38659
    Abstract: The compounds of formula in which the symbols R1, R2, R3 and R4 represent independently from each other a hydrogen atom or a methyl or ethyl group, the symbol X represents an oxygen atom or an alkylene group of formula in which n is an integer from 1 to 3, the symbols R6 and R7 represent each a hydrogen atom or a methyl or ethyl group, and R5 represents an alkyl or alkoxy group from C1 to C4, linear or branched, an alkenyl group from C2 to C4, linear or branched, or a group of formula in which Y has the same meaning as X and R8 is a linear or branched alkyl group from C1 to C4 or a linear or branched alkenyl group from C2 to C4, are novel compounds showing musky odors and which confer musky-velvety, voluminous and very tenacious notes to the products to which they are added.
    Type: Grant
    Filed: December 23, 2002
    Date of Patent: November 23, 2004
    Assignee: Firmenich SA
    Inventor: Alvin S. Williams